Table.
Phase 1* (n=1264) | Phase 2 (n=1258)† | Significance | |
---|---|---|---|
No of patients taking aspirin | 957 | 1058 | — |
No (%) of patients with contraindication to aspirin | 127 (10.0) | 163 (13.0) | — |
% of patients treated, excluding those with contraindication (95% CI) | 84.2 (81.9 to 86.2) | 96.6 (95.4 to 97.6) | χ2=97.1, P<0.0001 |
All eligible patients were receiving aspirin in 12 practices.
Excludes six patients who had been given incorrect diagnosis, who had died, or who had moved away.